Link Pharma Chem (BSE 524748)₹25.45−0.20%Commodity Chemicals
Link Pharma Chem is compared with the 10 closest in size in Commodity Chemicals (80 companies in the industry). It has a ROCE of 3.5% against a peer median of 2.8%, and latest-quarter sales growth of 12.4% against a peer median of 12.4%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Commodity Chemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pentokey Organy (India) | 18 | 87.7 | 2.1 | 2.1 | 0.00 | 0.0 | 2 | 0 | −408.3 | −271.4 | vs BSE 524748 |
| Vivid Global Industries | 17 | 21.0 | 12.0 | 4.7 | 0.11 | 0.0 | 54 | 1 | 43.7 | 20.0 | vs BSE 524748 |
| TECIL Chemicals and Hydro Power | 16 | — | — | — | — | 0.0 | 0 | −0 | — | — | vs BSE 524748 |
| Square Four Projects India | 15 | — | −1.2 | −1.5 | 0.09 | 0.0 | 0 | −0 | — | — | vs BSE 524748 |
| Emmessar Biotech & Nutrition | 12 | 29.2 | 7.3 | 5.6 | 0.00 | 0.0 | 0 | 0 | −30.0 | −22.2 | vs BSE 524748 |
| Link Pharma Chem | 11 | — | 3.5 | 0.6 | 0.57 | 0.0 | 27 | 0 | 12.4 | −19.5 | — |
| Lime Chemicals | 10 | — | −2.0 | −9.2 | 2.65 | 0.0 | 7 | −0 | 38.8 | −42.9 | vs BSE 524748 |
| Kuwer Industries | 9 | 5.3 | 8.9 | 10.5 | 1.81 | 0.0 | 73 | 2 | 118.9 | — | vs BSE 524748 |
| Sreechem Resins | 9 | — | −0.6 | −1.6 | 0.20 | 0.0 | 30 | −0 | −11.2 | 92.7 | vs BSE 524748 |
| Kobo Biotech | 8 | — | −125.5 | — | — | 0.0 | 0 | −5 | — | — | vs BSE 524748 |
| Bhagawati Oxygen | 8 | 2.6 | 49.0 | 58.3 | 0.15 | 0.0 | 0 | 3 | — | 2,400.0 | vs BSE 524748 |
| Peer median | 11 | 21.0 | 2.8 | 2.1 | 0.15 | 0.0 | 2 | 0 | 12.4 | −19.5 |
Listed companies closest to Link Pharma Chem in Commodity Chemicals include Pentokey Organy (India), Vivid Global Industries, TECIL Chemicals and Hydro Power, Square Four Projects India, Emmessar Biotech & Nutrition, Lime Chemicals, Kuwer Industries, Sreechem Resins.
Pentokey Organy (India), with a market cap of ₹17.68 Cr.
Link Pharma Chem's return on capital employed is 3.5%, above the peer median of 2.8%.